HAMMERHEAD RIBOZYME-MEDIATED CLEAVAGE OF THE LONG TERMINAL REPEAT RNA OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1

被引:0
|
作者
HEIDENREICH, O [1 ]
ECKSTEIN, F [1 ]
机构
[1] MAX PLANCK INST EXPTL MED, HERMANN REIN STR 3, W-3400 GOTTINGEN, GERMANY
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Three ribozymes targeted against different sites of the long terminal repeat RNA (LTR RNA) of human immunodeficiency virus type 1 cleaved a LTR RNA transcript 1,000 x less efficiently than corresponding short synthetic oligoribonucleotide substrates. Varying the stem lengths of the ribozyme resulted in changes of the catalytic efficiency. Almost no cleavage was observed for a ribozyme forming only 10 base pairs instead of 14 with the LTR RNA. Increasing the base pairs to 16 or elongation of the stem formed within the ribozyme revealed only small changes in k(cat)/K(m). The influence of chemical modifications within the ribozyme on the cleavage of the LTR RNA was also examined. 2'-Fluorocytidine substitutions as well as four terminal phosphorothioate internucleotidic linkages influenced the catalytic efficiency of ribozymes only negligibly. However, substitution of uridine by 2'-fluorouridine resulted in a 5-fold decrease of k(cat)/K(m). A ribozyme containing all these modifications revealed only a 7-fold lower catalytic efficiency but a markedly increased stability in cell culture supernatant. These results demonstrate that it is possible to increase the stability of ribozymes toward nucleases without a serious loss in catalytic efficiency.
引用
收藏
页码:1904 / 1909
页数:6
相关论文
共 50 条
  • [31] EVOLUTION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 NEF AND LONG TERMINAL REPEAT SEQUENCES OVER 4 YEARS INVIVO AND INVITRO
    DELASSUS, S
    CHEYNIER, R
    WAINHOBSON, S
    JOURNAL OF VIROLOGY, 1991, 65 (01) : 225 - 231
  • [32] AN INVITRO TRANSCRIPTION ANALYSIS OF EARLY RESPONSES OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 LONG TERMINAL REPEAT TO DIFFERENT TRANSCRIPTIONAL ACTIVATORS
    LI, YC
    ROSS, J
    SCHEPPLER, JA
    FRANZA, BR
    MOLECULAR AND CELLULAR BIOLOGY, 1991, 11 (04) : 1883 - 1893
  • [33] A HAIRPIN RIBOZYME INHIBITS EXPRESSION OF DIVERSE STRAINS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    YU, M
    OJWANG, J
    YAMADA, O
    HAMPEL, A
    RAPAPPORT, J
    LOONEY, D
    WONGSTAAL, F
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (13) : 6340 - 6344
  • [34] A two-metal ion mechanism operates in the hammerhead ribozyme-mediated cleavage of an RNA substrate
    Lott, WB
    Pontius, BW
    von Hippel, PH
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (02) : 542 - 547
  • [35] 3 INHIBITORS OF TYPE-1 HUMAN-IMMUNODEFICIENCY-VIRUS LONG TERMINAL REPEAT-DIRECTED GENE-EXPRESSION AND VIRUS-REPLICATION
    LI, CJ
    ZHANG, LJ
    DEZUBE, BJ
    CRUMPACKER, CS
    PARDEE, AB
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (05) : 1839 - 1842
  • [36] IMMUNOGLOBULIN A-MEDIATED NEUTRALIZATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    BURNETT, PR
    POLONIS, V
    VANCOTT, TC
    BIRX, DL
    REDFIELD, RR
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1994, 10 : S34 - S34
  • [37] MORPHOGENESIS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    CHATTERJEE, S
    BASAK, S
    KHAN, NC
    PATHOBIOLOGY, 1992, 60 (04) : 181 - 186
  • [38] RADIOSENSITIVITY OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    CONWAY, B
    TOMFORD, WW
    CLINICAL INFECTIOUS DISEASES, 1992, 14 (04) : 978 - 979
  • [39] THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 LONG TERMINAL REPEAT IS ACTIVATED BY MONOFUNCTIONAL AND BIFUNCTIONAL DNA ALKYLATING-AGENTS IN HUMAN-LYMPHOCYTES
    QUINTO, I
    RUOCCO, MR
    BALDASSARRE, F
    MALLARDO, M
    DRAGONETTI, E
    SCALA, G
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1993, 268 (35) : 26719 - 26724
  • [40] VARIANTS OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    TOURNIER, JN
    VERRIER, B
    BIRON, FF
    MANDRAND, B
    PEYRAMOND, D
    MEDECINE ET MALADIES INFECTIEUSES, 1995, 25 (05): : 709 - 715